These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8787526)

  • 1. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
    Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
    Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
    Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
    J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
    Stephens CP; Blackall PJ; Wade LK; Lowe LB
    Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens.
    Bousquet E; Morvan H; Aitken I; Morgan JH
    Vet Rec; 1997 Jul; 141(2):37-40. PubMed ID: 9253829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
    Stipkovits L; Miller D; Glavits R; Fodor L; Burch D
    Can J Vet Res; 2001 Oct; 65(4):213-22. PubMed ID: 11768127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs.
    Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A
    J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
    J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.
    Fittipaldi N; Klopfenstein C; Gottschalk M; Broes A; Paradis MA; Dick CP
    Can J Vet Res; 2005 Apr; 69(2):146-50. PubMed ID: 15971680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotypes and antimicrobial resistance patterns of the recent Korean Actinobacillus pleuropneumoniae isolates.
    Yoo AN; Cha SB; Shin MK; Won HK; Kim EH; Choi HW; Yoo HS
    Vet Rec; 2014 Mar; 174(9):223. PubMed ID: 24552671
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.
    Dong Z; Zhou XZ; Sun JC; Meng XB; Li HS; Cheng FS; Wei XJ; Li B; Wang WW; Zhang JY
    Vet Med Sci; 2020 Feb; 6(1):105-113. PubMed ID: 31589010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of A pleuropneumoniae and P multocida to ceftiofur.
    Hewett GR
    Vet Rec; 1994 Feb; 134(8):200. PubMed ID: 8171805
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests.
    Aarestrup FM; Jensen NE
    Vet Microbiol; 1999 Feb; 64(4):299-305. PubMed ID: 10063535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
    Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
    J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida.
    Lim J; Yun H
    Int J Antimicrob Agents; 2001 Jun; 17(6):471-6. PubMed ID: 11397617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.